🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluation of the mechanism of Action of talimogene laherparepvec (T-VEC) i...
Status
Completed
Location
Department of Dermatology, University Hospital Zurich
Start Date
2018-04-19
Trial ID
NCT03458117
Treatments Being Tested
This is an open-label, single-arm, Phase II investigator-initiated trial of...
Status
Unknown
Location
The Second Affiliated Hospital of SchoowUniversity
Start Date
2023-04-01
Trial ID
NCT05790447
Treatments Being Tested
RATIONALE: Biological therapies, such as GM-CSF, may stimulate the immune s...
Status
Unknown
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00893477
This study is being conducted in order determine whether IMA910 as single a...
Status
Completed
Location
Medische Oncologie, Imeldaziekenhuis
Start Date
2008-06
Trial ID
NCT00785122
Treatments Being Tested
This study was conducted in order to evaluate the efficacy and safety of th...
Status
Completed
Location
Medizinische Universität Salzburg - Universitätsklinik für Innere Medizin III
Start Date
2007-05
Trial ID
NCT00523159
Treatments Being Tested
The main purpose of this study was to determine whether ADT started before ...
Status
Completed
Location
Urology Center of Alabama
Start Date
2011-09
Trial ID
NCT01431391
Treatments Being Tested
UV1 is a therapeutic cancer vaccine that has been explored in prostate and ...
Status
Completed
Location
John Wayne Cancer Center
Start Date
2018-07-09
Trial ID
NCT03538314
This study will investigate the safety and efficacy of the administration o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-03
Trial ID
NCT02601365
Treatments Being Tested
The purpose of this study is to evaluate whether treatment with rituximab p...
Status
Terminated
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00308087
Treatments Being Tested
This study is an open-label, Phase Ib clinical study to evaluate recombinan...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2019-05-27
Trial ID
NCT04197882
Treatments Being Tested